Foresite Capital Management V, LLC Pardes Biosciences, Inc. Transaction History

Foresite Capital Management V, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.4 - $1.95 $1.08 Million - $1.51 Million	773,952 Added 7.71%	10,811,887 $19.6 Million
Q4 2022 Feb 13, 2023	BUY	$0.85 - $1.69 $541,807 - $1.08 Million	637,420 Added 6.78%	10,037,935 $17 Million
Q4 2021 Feb 11, 2022	BUY	$9.8 - $17.02 $92.1 Million - $160 Million	9,400,515 New	9,400,515 $154 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management V, LLC with notifications on news.